Literature DB >> 7831762

Pharmacokinetics and dosage regimen of cefotaxime in cross-bred calves following single intramuscular administration.

S K Sharma1, A K Srivastava.   

Abstract

The pharmacokinetics, penetration into erythrocytes and plasma protein binding of cefotaxime were investigated in cross-bred calves. Following a single intramuscular dose of cefotaxime (10 mg/kg), the absorption half-life and elimination half-life were 0.13 +/- 0.03 h and 2.97 +/- 0.72 h, respectively. The apparent volume of distribution and total body clearance were 3.28 +/- 0.72 L/kg and 0.78 +/- 0.08 L/kg per h, respectively. The extent of penetration into erythrocytes was 24-40% of the total blood concentration. Cefotaxime was bound to plasma proteins of calves to the extent of 25.5-33.6%. A satisfactory intramuscular dosage regimen for cefotaxime in calves would be 11 mg/kg followed by 10 mg/kg at 7 h intervals.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7831762     DOI: 10.1007/bf01839199

Source DB:  PubMed          Journal:  Vet Res Commun        ISSN: 0165-7380            Impact factor:   2.459


  13 in total

1.  Pharmacokinetics, plasma protein binding and dosage of oxytetracycline in cattle and horses.

Authors:  M Pilloud
Journal:  Res Vet Sci       Date:  1973-09       Impact factor: 2.534

2.  Pharmacokinetics of cefotaxime and probenecid in sheep with normal and reduced renal function.

Authors:  V H Guerrini; L J Filippich; P B English; G R Cao; D W Bourne
Journal:  J Vet Pharmacol Ther       Date:  1984-12       Impact factor: 1.786

Review 3.  The in vitro activity, human pharmacology, and clinical effectiveness of new beta-lactam antibiotics.

Authors:  H C Neu
Journal:  Annu Rev Pharmacol Toxicol       Date:  1982       Impact factor: 13.820

4.  Pharmacokinetics of cefotaxime in sheep.

Authors:  V H Guerrini; L Filippich; P B English; D W Bourne
Journal:  Am J Vet Res       Date:  1983-08       Impact factor: 1.156

Review 5.  The new beta-lactamase-stable cephalosporins.

Authors:  H C Neu
Journal:  Ann Intern Med       Date:  1982-09       Impact factor: 25.391

6.  Outline of details for microbiological assays of antibiotics: second revision.

Authors:  B Arret; D P Johnson; A Kirshbaum
Journal:  J Pharm Sci       Date:  1971-11       Impact factor: 3.534

7.  Pharmacokinetic evaluation of a slow-release cefotaxime suspension in the dog and in sheep.

Authors:  V H Guerrini; P B English; L J Filippich; J Schneider; D W Bourne
Journal:  Am J Vet Res       Date:  1986-09       Impact factor: 1.156

8.  Pharmacokinetics of cefotaxime in the domestic cat.

Authors:  D McElroy; W R Ravis; C H Clark
Journal:  Am J Vet Res       Date:  1986-01       Impact factor: 1.156

9.  HR 756, a new cephalosporin active against gram-positive and gram-negative aerobic and anaerobic bacteria.

Authors:  H C Neu; N Aswapokee; P Aswapokee; K P Fu
Journal:  Antimicrob Agents Chemother       Date:  1979-02       Impact factor: 5.191

10.  Kinetic interactions between azlocillin, cefotaxime, and cefotaxime metabolites in normal and impaired renal function.

Authors:  D Kampf; K Borner; M Möller; M Kessel
Journal:  Clin Pharmacol Ther       Date:  1984-02       Impact factor: 6.875

View more
  2 in total

1.  Mixed Micelles Loaded with Bile Salt: An Approach to Enhance Intestinal Transport of the BCS Class III Drug Cefotaxime in Rats.

Authors:  Mosab Arafat; Cathrin Kirchhoefer; Momir Mikov
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2017-08       Impact factor: 2.441

2.  Subcutaneous pharmacokinetics and dosage regimen of cefotaxime in buffalo calves (Bubalus bubalis).

Authors:  Suresh Kumar Sharma; Anil Kumar Srivastava
Journal:  J Vet Sci       Date:  2006-06       Impact factor: 1.672

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.